Skip to main content
Top
Published in: Brain Tumor Pathology 1/2020

01-01-2020 | Lymphoma | Original Article

Ventricle-predominant primary CNS lymphomas: clinical, radiological and pathological evaluation of five cases and review of the literature

Authors: Matthew K. Ball, Jonathan M. Morris, Adam J. Wood, Fredric B. Meyer, Megan C. Kaszuba, Aditya Raghunathan

Published in: Brain Tumor Pathology | Issue 1/2020

Login to get access

Abstract

Primary central nervous system lymphomas (PCNSLs) are typically intraparenchymal. A subset of PCNSLs predominantly arises in the ventricles, with minimal parenchymal involvement. We review the clinical, radiological, and pathological features of ventricle-predominant PCNSLs (VP-PCNSLs) in 40 previously reported cases and report 5 additional cases. Including all cases of VP-PCNSLs (n = 45), 38% were diffuse large B-cell lymphomas (DLBCL), 11% were Burkitt lymphomas, 7% were MALT lymphomas, 4% were T-cell lymphomas, and 40% were lymphomas, not otherwise classified. VP-PCNSLs show rapid clinical progression. Patients present at a median age of 60.5 years. Unique clinical and radiological features distinguish them from other intraventricular tumors, including advanced age, edema, multifocality, hyperdensity, early and avid post-contrast enhancement, restricted diffusion, and positron emission tomography (PET) hypermetabolism. Including our cases, which were all DLBCL, and all previously reported DLBCL cases (n = 10), 8 of 10 show germinal center B-cell-like (GCB) phenotype, contrasting the high prevalence of non-germinal center B-cell-like (non-GCB) phenotype of parenchymal DLBCL PCNSLs. MYD88 L265P mutation was detected in three of our five cases. Ventricle-predominant PCNSLs are clinically and radiologically distinct, and the DLBCLs may be pathologically distinct. Further recognition of this entity may help to evaluate the role of therapies, possibly including surgical resection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, Von Deimling A (2016) WHO Classification of tumours of the central nervous system. World Health Organization classification of tumours, Revised 4th edn. Stylus Publishing, Herndon Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, Von Deimling A (2016) WHO Classification of tumours of the central nervous system. World Health Organization classification of tumours, Revised 4th edn. Stylus Publishing, Herndon
2.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours, Revised 4th edn. Stylus Publishing, Herndon Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours, Revised 4th edn. Stylus Publishing, Herndon
4.
go back to reference Buhring U, Herrlinger U, Krings T, Thiex R, Weller M, Kuker W (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57(3):393–396CrossRefPubMed Buhring U, Herrlinger U, Krings T, Thiex R, Weller M, Kuker W (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57(3):393–396CrossRefPubMed
18.
go back to reference Terasaki M, Abe T, Tajima Y, Fukushima S, Hirohata M, Shigemori M (2006) Primary choroid plexus T-cell lymphoma and multiple aneurysms in the CNS. Leukemia Lymphoma 47(8):1680–1682CrossRefPubMed Terasaki M, Abe T, Tajima Y, Fukushima S, Hirohata M, Shigemori M (2006) Primary choroid plexus T-cell lymphoma and multiple aneurysms in the CNS. Leukemia Lymphoma 47(8):1680–1682CrossRefPubMed
26.
go back to reference Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J (2002) Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12(2):329–340CrossRefPubMed Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J (2002) Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12(2):329–340CrossRefPubMed
29.
go back to reference Camilleri-Broet S, Criniere E, Broet P, Delwail V, Mokhtari K, Moreau A, Kujas M, Raphael M, Iraqi W, Sautes-Fridman C, Colombat P, Hoang-Xuan K, Martin A (2006) A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107(1):190–196. https://doi.org/10.1182/blood-2005-03-1024 CrossRefPubMed Camilleri-Broet S, Criniere E, Broet P, Delwail V, Mokhtari K, Moreau A, Kujas M, Raphael M, Iraqi W, Sautes-Fridman C, Colombat P, Hoang-Xuan K, Martin A (2006) A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107(1):190–196. https://​doi.​org/​10.​1182/​blood-2005-03-1024 CrossRefPubMed
30.
go back to reference Brunn A, Nagel I, Montesinos-Rongen M, Klapper W, Vater I, Paulus W, Hans V, Blumcke I, Weis J, Siebert R, Deckert M (2013) Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. Acta Neuropathol 126(4):603–605. https://doi.org/10.1007/s00401-013-1169-7 CrossRefPubMed Brunn A, Nagel I, Montesinos-Rongen M, Klapper W, Vater I, Paulus W, Hans V, Blumcke I, Weis J, Siebert R, Deckert M (2013) Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. Acta Neuropathol 126(4):603–605. https://​doi.​org/​10.​1007/​s00401-013-1169-7 CrossRefPubMed
32.
go back to reference Nakamura T, Tateishi K, Niwa T, Matsushita Y, Tamura K, Kinoshita M, Tanaka K, Fukushima S, Takami H, Arita H, Kubo A, Shuto T, Ohno M, Miyakita Y, Kocialkowski S, Sasayama T, Hashimoto N, Maehara T, Shibui S, Ushijima T, Kawahara N, Narita Y, Ichimura K (2016) Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas. Neuropathol Appl Neurobiol 42(3):279–290. https://doi.org/10.1111/nan.12259 CrossRefPubMed Nakamura T, Tateishi K, Niwa T, Matsushita Y, Tamura K, Kinoshita M, Tanaka K, Fukushima S, Takami H, Arita H, Kubo A, Shuto T, Ohno M, Miyakita Y, Kocialkowski S, Sasayama T, Hashimoto N, Maehara T, Shibui S, Ushijima T, Kawahara N, Narita Y, Ichimura K (2016) Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas. Neuropathol Appl Neurobiol 42(3):279–290. https://​doi.​org/​10.​1111/​nan.​12259 CrossRefPubMed
33.
go back to reference Takano S, Hattori K, Ishikawa E, Narita Y, Iwadate Y, Yamaguchi F, Nagane M, Akimoto J, Oka H, Tanaka S, Sakata M, Matsuda M, Yamamoto T, Chiba S, Matsumura A (2018) MyD88 mutation in elderly predicts poor prognosis in primary central nervous system lymphoma: multi-institutional analysis. World Neurosurg 112:e69–e73. https://doi.org/10.1016/j.wneu.2017.12.028 CrossRefPubMed Takano S, Hattori K, Ishikawa E, Narita Y, Iwadate Y, Yamaguchi F, Nagane M, Akimoto J, Oka H, Tanaka S, Sakata M, Matsuda M, Yamamoto T, Chiba S, Matsumura A (2018) MyD88 mutation in elderly predicts poor prognosis in primary central nervous system lymphoma: multi-institutional analysis. World Neurosurg 112:e69–e73. https://​doi.​org/​10.​1016/​j.​wneu.​2017.​12.​028 CrossRefPubMed
Metadata
Title
Ventricle-predominant primary CNS lymphomas: clinical, radiological and pathological evaluation of five cases and review of the literature
Authors
Matthew K. Ball
Jonathan M. Morris
Adam J. Wood
Fredric B. Meyer
Megan C. Kaszuba
Aditya Raghunathan
Publication date
01-01-2020
Publisher
Springer Singapore
Published in
Brain Tumor Pathology / Issue 1/2020
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-019-00354-x